|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
2,250,000,000 |
Market
Cap: |
91.01(B) |
Last
Volume: |
18,277,023 |
Avg
Vol: |
12,077,193 |
52
Week Range: |
$40.25 - $64.73 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 100 |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 97 |
Guru Rank Value : 8.6 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s primary products include: Revlimid®, in which Revlimid (lenalidomide) is an oral immunomodulatory drug that in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma; and Eliquis®, in which Eliquis (apixaban) is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
13,571 |
13,571 |
Total Buy Value |
$0 |
$0 |
$672,994 |
$672,994 |
Total People Bought |
0 |
0 |
2 |
2 |
Total Buy Transactions |
0 |
0 |
3 |
3 |
Total Shares Sold |
0 |
0 |
18,718 |
616,397 |
Total Sell Value |
$0 |
$0 |
$1,146,397 |
$44,859,834 |
Total People Sold |
0 |
0 |
2 |
5 |
Total Sell Transactions |
0 |
0 |
2 |
11 |
End Date |
2024-04-04 |
2024-01-02 |
2023-07-04 |
2022-07-04 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Andreotti Lamberto |
Chief Executive Officer |
|
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,531 |
416,594 |
|
- |
|
Moed Samuel J |
SVP, Strat Plan & Analysis |
|
2015-03-02 |
4 |
D |
$62.30 |
$75,881 |
D/D |
(1,218) |
35,610 |
|
- |
|
Moed Samuel J |
SVP, Strat Plan & Analysis |
|
2015-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,174 |
36,828 |
|
- |
|
Moed Samuel J |
SVP, Strat Plan & Analysis |
|
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,174 |
35,654 |
|
- |
|
Caforio Giovanni |
Chief Operating Officer |
|
2015-03-02 |
4 |
D |
$62.30 |
$69,402 |
D/D |
(1,114) |
47,273 |
|
- |
|
Caforio Giovanni |
Chief Operating Officer |
|
2015-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,494 |
48,387 |
|
- |
|
Caforio Giovanni |
Chief Operating Officer |
|
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,494 |
46,893 |
|
- |
|
Nielsen Anne |
Chief Compliance & Ethics Off |
|
2015-03-02 |
4 |
D |
$62.30 |
$52,581 |
D/D |
(844) |
44,552 |
|
- |
|
Nielsen Anne |
Chief Compliance & Ethics Off |
|
2015-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,033 |
45,396 |
|
- |
|
Nielsen Anne |
Chief Compliance & Ethics Off |
|
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,033 |
44,363 |
|
- |
|
Caldarella Joseph C |
SVP & Controller |
|
2015-03-02 |
4 |
D |
$62.30 |
$127,154 |
D/D |
(2,041) |
64,459 |
|
- |
|
Caldarella Joseph C |
SVP & Controller |
|
2015-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,475 |
66,500 |
|
- |
|
Caldarella Joseph C |
SVP & Controller |
|
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,475 |
64,025 |
|
- |
|
Leung Sandra |
General Counsel & Secretary |
|
2015-02-17 |
4 |
S |
$60.39 |
$709,282 |
D/D |
(11,746) |
263,910 |
|
- |
|
Leung Sandra |
General Counsel & Secretary |
|
2015-02-17 |
4 |
OE |
$25.45 |
$381,750 |
D/D |
15,000 |
275,656 |
|
- |
|
Moed Samuel J |
SVP, Strat Plan & Analysis |
|
2015-02-12 |
4 |
S |
$59.26 |
$229,933 |
D/D |
(3,880) |
34,480 |
|
- |
|
Moed Samuel J |
SVP, Strat Plan & Analysis |
|
2015-02-06 |
4 |
S |
$60.15 |
$1,291,988 |
D/D |
(21,478) |
38,360 |
|
- |
|
Moed Samuel J |
SVP, Strat Plan & Analysis |
|
2015-02-06 |
4 |
OE |
$22.14 |
$618,547 |
D/D |
27,938 |
59,838 |
|
- |
|
Cornelius James M |
Director |
|
2015-01-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
40,000 |
79,464 |
|
- |
|
Cornelius James M |
Director |
|
2015-01-30 |
4 |
S |
$60.60 |
$3,029,975 |
D/D |
(50,000) |
119,464 |
|
- |
|
Andreotti Lamberto |
Chief Executive Officer |
|
2015-01-29 |
4 |
S |
$61.14 |
$5,518,001 |
D/D |
(90,246) |
383,063 |
|
- |
|
Andreotti Lamberto |
Chief Executive Officer |
|
2015-01-29 |
4 |
OE |
$25.45 |
$2,863,125 |
D/D |
112,500 |
473,309 |
|
- |
|
Campbell Lewis B |
Director |
|
2015-01-29 |
4 |
S |
$60.89 |
$152,227 |
D/D |
(2,500) |
0 |
|
- |
|
Campbell Lewis B |
Director |
|
2015-01-29 |
4 |
OE |
$26.25 |
$65,625 |
D/D |
2,500 |
2,500 |
|
- |
|
Schmukler Louis S |
Pres., Global Mfg. & Supply |
|
2015-01-29 |
4 |
S |
$60.73 |
$318,850 |
D/D |
(5,250) |
14,182 |
|
- |
|
953 Records found
|
|
Page 37 of 39 |
|
|